Through the support from our project we published a new research paper in the journal Inorganics on the topic of using mesoporous silica nanoparticles for pH-responsive delivery of iridium metallotherapeutics and treatment of glioblastoma multiforme.Click on the link below to read the full paper: mesoporous silica nanoparticles for pH-responsive delivery of iridium metallotherapeutics and treatment of glioblastoma multiforme. pdf
Yesterday, NANOFACTS Project Coordinator, Dr. Nikola Knežević was a guest on Serbian national television presenting the project's objectives. Visit the following link to watch the TV show: https://www.youtube.com/watch?v=fccwBayWaSg (on Serbian only)
On April 13, Prof. Dr. Peter Ertl from the Vienna University of Technology was awarded the State Prize for the Promotion of Alternative Methods to Animal Experiments for his research work by the Austrian Federal Ministry of Education, Science and Research. Prof. Dr. Peter Ertl is working on the development of biochips intended to replace animal testing in medicines. We are honored to have such great partners!
Mirjana Mundžić from BioSense Institute have started her visit and training at Trinity College Dublin. She is going to work on a research in application of nanotechnology for cancer treatment and imaging.
NANOFACTS project coordinator, Dr. Nikola Knežević, participated in the management committee meeting of the COST action NETPORE. The action aims to bridge the gap between fundamental developments and practical applications of technologies based on porous materials. Participation in this action enhances the networking possibilities of BIOS researchers in the area of application of porous nanomaterials.
Mila Djisalov and Teodora Knežić from BioSense Institute are on their extended stay visits at the Vienna University of Technology. Currently, they are participating in a workshop “Microfluidics and Cell Culture”. They are going to design microfluidic chips for cell culturing. The aim of their visit is the development of microfluidic chips for Glioblastoma cell culturing, as well as the development of cancer spheroid-on-a-chip technology for Glioblastoma Multiforme.
A new year has started with great plans for future research and secondments! NANOFACTS consortium met to discuss forthcoming extended stay visits. We would like to thank to all participants who made the meeting successful!
On December 9th, NANOFACTS BIOS members had a meeting dedicated to the 1st secondment, where young researchers presented their experience and results. We are all thankful to have such devoted students and to have a chance to learn from their experiences.
NANOFACTS team members from BioSense Institute participated in the 5th Congress of the “Serbian Association for Cancer Research – SDIR”. It was very useful to hear more about the translational potential of cancer research in Serbia. We hope that NANOFACTS project will contribute to this topic in the future.